The FDA has identified potential safety concerns involving compounded injectable GHK-Cu, including possible immunogenicity related to peptide aggregation or impurities, and notes that human safety information is limited
For example, older people might need to get injections more frequently, as do those who have digestive absorption issues or autoimmune conditions
This article focuses specifically on the formulation aspects that matter most to cosmetic science professionals: mechanism of action, recommended dosage ranges, compatibility considerations, and regulatory guidance
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis
Consequently, it is not surprising that the respiratory chain is rich in Fe-S clusters that help channel electrons (Fig
Similarly, combining thymosin alpha-1 immune regulation with biologic therapy could produce unpredictable immune effects